High constitutive activity of native H3 receptors regulates histamine neurons in brain

被引:387
作者
Morisset, S
Rouleau, A
Ligneau, X
Gbahou, F
Tardivel-Lacombe, J
Stark, H
Schunack, W
Ganellin, CR
Schwartz, JC
Arrang, JM
机构
[1] Ctr Paul Broca, INSERM, U109, Unite Neurobiol & Pharmacol Mol, F-75014 Paris, France
[2] Lab Bioprojet, F-75002 Paris, France
[3] Free Univ Berlin, Inst Pharm, D-14195 Berlin, Germany
[4] UCL, Christopher Ingold Labs, Dept Chem, London WC1H 0AJ, England
关键词
D O I
10.1038/35048583
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Some G-protein-coupled receptors display 'constitutive activity', that is, spontaneous activity in the absence of agonist(1-4). This means that a proportion of the receptor population spontaneously undergoes an allosteric transition, leading to a conformation that can bind G proteins(3). The process has been shown to occur with recombinant receptors expressed at high density, and/or mutated, but also non-mutated recombinant receptors expressed at physiological concentrations(5-7). Transgenic mice that express a constitutively active mutant of the beta (2)-adrenergic receptor display cardiac anomalies(8); and spontaneous receptor mutations leading to constitutive activity are at the origin of some human diseases(9,10). Nevertheless, this process has not previously been found to occur in animals expressing normal levels of receptor(3,4). Here we show that two isoforms of the recombinant rat H(3) receptor(11,12) display high constitutive activity. Using drugs that abrogate this activity ('inverse agonists') and a drug that opposes both agonists and inverse agonists ('neutral antagonist'), we show that constitutive activity of native H(3) receptors is present in rodent brain and that it controls histaminergic neuron activity in vivo. Inverse agonists may therefore rnd therapeutic applications, even in the case of diseases involving non-mutated receptors expressed at normal levels.
引用
收藏
页码:860 / 864
页数:6
相关论文
共 30 条
[1]   AUTO-INHIBITION OF BRAIN HISTAMINE-RELEASE MEDIATED BY A NOVEL CLASS (H-3) OF HISTAMINE-RECEPTOR [J].
ARRANG, JM ;
GARBARG, M ;
SCHWARTZ, JC .
NATURE, 1983, 302 (5911) :832-837
[2]   AUTO-REGULATION OF HISTAMINE-RELEASE IN BRAIN BY PRESYNAPTIC H-3-RECEPTORS [J].
ARRANG, JM ;
GARBARG, M ;
SCHWARTZ, JC .
NEUROSCIENCE, 1985, 15 (02) :553-562
[3]   HIGHLY POTENT AND SELECTIVE LIGANDS FOR HISTAMINE RECEPTORS-H-3 [J].
ARRANG, JM ;
GARBARG, M ;
LANCELOT, JC ;
LECOMTE, JM ;
POLLARD, H ;
ROBBA, M ;
SCHUNACK, W ;
SCHWARTZ, JC .
NATURE, 1987, 327 (6118) :117-123
[4]  
Berg KA, 1999, MOL PHARMACOL, V55, P863
[5]   PHYSIOLOGICAL-EFFECTS OF INVERSE AGONISTS IN TRANSGENIC MICE WITH MYOCARDIAL OVEREXPRESSION OF THE BETA(2)-ADRENOCEPTOR [J].
BOND, RA ;
LEFF, P ;
JOHNSON, TD ;
MILANO, CA ;
ROCKMAN, HA ;
MCMINN, TR ;
APPARSUNDARAM, S ;
HYEK, MF ;
KENAKIN, TP ;
ALLEN, LF ;
LEFKOWITZ, RJ .
NATURE, 1995, 374 (6519) :272-276
[6]  
Claeysen S, 1999, MOL PHARMACOL, V55, P910
[7]   Sensitivity of histamine H-3 receptor agonist-stimulated [S-35]GTP gamma[S] binding to pertussis toxin [J].
Clark, EA ;
Hill, SJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 296 (02) :223-225
[8]   DIFFERENTIAL EFFECT OF SODIUM-IONS AND GUANINE-NUCLEOTIDES ON THE BINDING OF THIOPERAMIDE AND CLOBENPROPIT TO HISTAMINE H-3 RECEPTORS IN RAT CEREBRAL CORTICAL MEMBRANES [J].
CLARK, EA ;
HILL, SJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (02) :357-362
[9]  
COSTA T, 1992, MOL PHARMACOL, V41, P549
[10]  
GARBARG M, 1992, J PHARMACOL EXP THER, V263, P304